What are Inactivated pentavalent vaccine drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inactivated pentavalent vaccine drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 2 more in clinical development.

Inactivated pentavalent vaccine

0 marketed 2 in Phase 3

This page covers all Inactivated pentavalent vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (2)

DTaP-IPV//PRP~T combined vaccine · Sanofi · Immunology / Infectious Disease
This combined vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.
DPT-IPV-Hib-Low（Combined Vaccine） · Tanabe Pharma Corporation · Immunology / Infectious Disease Prevention
This combined vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, pertussis, tetanus, poliomyelitis, and Haemophilus influenzae type b pathogens.

Patent intelligence

inactivated pentavalent vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates